| Chen Bihua |
CEO and Chairperson |
Helix Acquisition Corp. II (HLXB)
|
2024-02-13 |
$10.00 |
3.3% |
2,400,000
|
$24,000,000 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-10-05 |
$59.90 |
-23.9% |
58,839
|
$3,524,297 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-10-04 |
$57.30 |
-20.5% |
293,212
|
$16,800,343 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-06-30 |
$50.00 |
-8.8% |
800,000
|
$40,000,000 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-06-26 |
$45.63 |
-0.1% |
450,000
|
$20,535,012 |
| Chen Bihua |
Non-Executive Director |
Biomea Fusion, Inc. (BMEA)
|
2023-03-30 |
$30.00 |
-74.6% |
400,000
|
$12,000,000 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-03-21 |
$20.28 |
124.7% |
827,100
|
$16,774,846 |
| Chen Bihua |
Non-Executive Director |
Erasca, Inc. (ERAS)
|
2022-12-13 |
$6.50 |
-54.0% |
307,692
|
$1,999,998 |
| Chen Bihua |
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2022-04-05 |
$10.00 |
355.8% |
2,850,000
|
$28,500,000 |
| Chen Bihua |
Non-Executive Director |
Erasca, Inc. (ERAS)
|
2021-08-10 |
$22.10 |
-86.5% |
200,000
|
$4,420,000 |
| Chen Bihua |
Non-Executive Director |
Erasca, Inc. (ERAS)
|
2021-07-20 |
$16.00 |
-81.3% |
950,000
|
$15,200,000 |
| Chen Bihua |
Non-Executive Director |
Biomea Fusion, Inc. (BMEA)
|
2021-04-20 |
$17.00 |
-55.2% |
900,000
|
$15,300,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
40.5% |
$80,612,717 |
$199,054,496 |